User: Guest  Login
Document type:
journal article 
Author(s):
Rommer, P S; Zettl, U K; Kieseier, B; Hartung, H-P; Menge, T; Frohman, E; Greenberg, B M; Hemmer, B; Stüve, O 
Title:
Requirement for safety monitoring for approved multiple sclerosis therapies: an overview. 
Abstract:
During the last two decades, treatment options for patients with multiple sclerosis (MS) have broadened tremendously. All agents that are currently approved for clinical use have potential side effects, and a careful risk-benefit evaluation is part of a decision algorithm to identify the optimal treatment choice for an individual patient. Whereas glatiramer acetate and interferon beta preparations have been used in MS for decades and have a proven safety record, more recently approved drugs appe...    »
 
Journal title abbreviation:
Clin Exp Immunol 
Year:
2014 
Journal volume:
175 
Journal issue:
Pages contribution:
397-407 
Language:
eng 
Print-ISSN:
0009-9104 
TUM Institution:
Neurologische Klinik und Poliklinik